Deane et al. found that only 1 of 31 patients with a positive ANA and no evidence of autoimmunity at initial evaluation did develop a non-rheumatologic autoimmune disorder, indicating a very low rate of progression (2). The gene discussed is BTG3; the disease is autoimmune disease.